PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?
Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members.
Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members.
When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases, people wait too long, leaving an ER visit as the path of least resistance.
Financial wellness cannot depend solely on education. It requires addressing the real obstacles that prevent employees from achieving financial stability. Medical debt is one of those obstacles.
A comment docket dominated by hospital lobby framing produces a rule that reflects that framing. A comment docket that includes documented employer cost analysis, physician ownership experience, and market structure argument produces a different rule.
The question isn’t whether costs will rise. It’s whether employers will continue managing around the margins — or address the root cause.
Benefits leaders have become increasingly sophisticated in managing pharmacy spend and high-cost claims. MSK deserves similar strategic attention – not only because it is expensive, but because it is largely preventable.
This is forcing brokers to rethink how they serve clients and how their businesses continue to grow without sacrificing service.
This is not a debate about care models or physician preferences. It is a contest over who will control the referral pathways and the revenue streams that originate at the front door of healthcare.
More brokers are introducing medical gap insurance, more employers are adopting it, and more employees are benefiting from the added protection. The next step is making sure awareness keeps pace with need.
Executives who think ahead and ask the right questions – monthly – can make a real difference in healthcare costs.
When tax-advantaged dollars enter a care model, they do more than expand purchasing power. They reorganize incentives, accelerate intermediary involvement, and clarify who holds leverage.
Concierge and direct primary care models have proven their value as retention tools. Those who view these programs as measurable business assets, not ancillary benefits, will lead the next wave of workforce health innovation.
Despite its impact, metabolic health rarely appears on the HR dashboard. That oversight is costing employers more than they realize.